Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005993464> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2005993464 endingPage "S277" @default.
- W2005993464 startingPage "S277" @default.
- W2005993464 abstract "ObjectiveThe aim of our study is to compare the ICSI outcome of coasted and non-coasted hyperresponder cycles.DesignRetrospective case-control studyMaterials and methodsFifty-two consecutive coasted and 86 non-coasted hyperresponder ICSI cycles were enrolled retrospectively via our computerized IVF database system from January 2001 to January 2004. All patients in coasted and non-coasted groups underwent controlled ovarian hyperstimulation consisting of luteal-long leuprolide acetate (Lucrin; Abbott, Cedex, Istanbul) with oral contraceptive pre-treatment (Lo-ovral; Wyeth, Istanbul) and recombinant FSH (Gonal-F; Serono, Istanbul) using the step-down protocol. Hyperresponse was considered when the serum E2 level >4,500 pg/mL with/without the hCG criteria (>3 follicles ≥17 mm in diameter). Two strategies were employed for hyperresponders: 1) coasting (n=52 cycles) and 2) immediate administration of hCG (10,000 IU) without coasting (n=86 cycles). Non-coasted patients were informed about the possible adverse affect of non-coasting including OHSS before the administration of hCG and were all chose the immediate administration of hCG. In coasted group, gonadotropin injections were withdrawn while the GnRH agonist was continued. Daily E2 was measured until serum levels dropped below 4500 pg/mL. Then, administration of hCG (10,000 IU, Profasi, Serono, Istanbul) was employed. The Chi-square and Fisher’s Exact test were used to analyze nominal variables in the form of frequency tables. Normally distributed (Kolmogorov-Smirnov test) parametric variables were tested by independent sample t test. Non-normally distributed metric variables were analyzed by Mann-Whitney U-test. Values were expressed as mean ±SD, unless stated otherwise.ResultsTabled 1Tabled 1ConclusionCoasting may be a viable option in hyperresponder cycles undergoing ICSI. There appears to be no detrimental effect on embryo quality and pregnancy rates are highly acceptable. Although, the numbers are limited, coasting does not eliminate totally the risk of severe OHSS necessitating hospitalization. ObjectiveThe aim of our study is to compare the ICSI outcome of coasted and non-coasted hyperresponder cycles. The aim of our study is to compare the ICSI outcome of coasted and non-coasted hyperresponder cycles. DesignRetrospective case-control study Retrospective case-control study Materials and methodsFifty-two consecutive coasted and 86 non-coasted hyperresponder ICSI cycles were enrolled retrospectively via our computerized IVF database system from January 2001 to January 2004. All patients in coasted and non-coasted groups underwent controlled ovarian hyperstimulation consisting of luteal-long leuprolide acetate (Lucrin; Abbott, Cedex, Istanbul) with oral contraceptive pre-treatment (Lo-ovral; Wyeth, Istanbul) and recombinant FSH (Gonal-F; Serono, Istanbul) using the step-down protocol. Hyperresponse was considered when the serum E2 level >4,500 pg/mL with/without the hCG criteria (>3 follicles ≥17 mm in diameter). Two strategies were employed for hyperresponders: 1) coasting (n=52 cycles) and 2) immediate administration of hCG (10,000 IU) without coasting (n=86 cycles). Non-coasted patients were informed about the possible adverse affect of non-coasting including OHSS before the administration of hCG and were all chose the immediate administration of hCG. In coasted group, gonadotropin injections were withdrawn while the GnRH agonist was continued. Daily E2 was measured until serum levels dropped below 4500 pg/mL. Then, administration of hCG (10,000 IU, Profasi, Serono, Istanbul) was employed. The Chi-square and Fisher’s Exact test were used to analyze nominal variables in the form of frequency tables. Normally distributed (Kolmogorov-Smirnov test) parametric variables were tested by independent sample t test. Non-normally distributed metric variables were analyzed by Mann-Whitney U-test. Values were expressed as mean ±SD, unless stated otherwise. Fifty-two consecutive coasted and 86 non-coasted hyperresponder ICSI cycles were enrolled retrospectively via our computerized IVF database system from January 2001 to January 2004. All patients in coasted and non-coasted groups underwent controlled ovarian hyperstimulation consisting of luteal-long leuprolide acetate (Lucrin; Abbott, Cedex, Istanbul) with oral contraceptive pre-treatment (Lo-ovral; Wyeth, Istanbul) and recombinant FSH (Gonal-F; Serono, Istanbul) using the step-down protocol. Hyperresponse was considered when the serum E2 level >4,500 pg/mL with/without the hCG criteria (>3 follicles ≥17 mm in diameter). Two strategies were employed for hyperresponders: 1) coasting (n=52 cycles) and 2) immediate administration of hCG (10,000 IU) without coasting (n=86 cycles). Non-coasted patients were informed about the possible adverse affect of non-coasting including OHSS before the administration of hCG and were all chose the immediate administration of hCG. In coasted group, gonadotropin injections were withdrawn while the GnRH agonist was continued. Daily E2 was measured until serum levels dropped below 4500 pg/mL. Then, administration of hCG (10,000 IU, Profasi, Serono, Istanbul) was employed. The Chi-square and Fisher’s Exact test were used to analyze nominal variables in the form of frequency tables. Normally distributed (Kolmogorov-Smirnov test) parametric variables were tested by independent sample t test. Non-normally distributed metric variables were analyzed by Mann-Whitney U-test. Values were expressed as mean ±SD, unless stated otherwise. ResultsTabled 1Tabled 1 ConclusionCoasting may be a viable option in hyperresponder cycles undergoing ICSI. There appears to be no detrimental effect on embryo quality and pregnancy rates are highly acceptable. Although, the numbers are limited, coasting does not eliminate totally the risk of severe OHSS necessitating hospitalization. Coasting may be a viable option in hyperresponder cycles undergoing ICSI. There appears to be no detrimental effect on embryo quality and pregnancy rates are highly acceptable. Although, the numbers are limited, coasting does not eliminate totally the risk of severe OHSS necessitating hospitalization." @default.
- W2005993464 created "2016-06-24" @default.
- W2005993464 creator A5012511049 @default.
- W2005993464 creator A5033723894 @default.
- W2005993464 creator A5056788801 @default.
- W2005993464 creator A5086296039 @default.
- W2005993464 date "2005-09-01" @default.
- W2005993464 modified "2023-09-26" @default.
- W2005993464 title "How to Deal Hyperresponders in ICSI? Coasting Versus Non-Coasting" @default.
- W2005993464 doi "https://doi.org/10.1016/j.fertnstert.2005.07.720" @default.
- W2005993464 hasPublicationYear "2005" @default.
- W2005993464 type Work @default.
- W2005993464 sameAs 2005993464 @default.
- W2005993464 citedByCount "0" @default.
- W2005993464 crossrefType "journal-article" @default.
- W2005993464 hasAuthorship W2005993464A5012511049 @default.
- W2005993464 hasAuthorship W2005993464A5033723894 @default.
- W2005993464 hasAuthorship W2005993464A5056788801 @default.
- W2005993464 hasAuthorship W2005993464A5086296039 @default.
- W2005993464 hasBestOaLocation W20059934641 @default.
- W2005993464 hasConcept C126322002 @default.
- W2005993464 hasConcept C143228043 @default.
- W2005993464 hasConcept C170493617 @default.
- W2005993464 hasConcept C187785154 @default.
- W2005993464 hasConcept C191093355 @default.
- W2005993464 hasConcept C2777886879 @default.
- W2005993464 hasConcept C2778782382 @default.
- W2005993464 hasConcept C2778938600 @default.
- W2005993464 hasConcept C2779234561 @default.
- W2005993464 hasConcept C2781065240 @default.
- W2005993464 hasConcept C29456083 @default.
- W2005993464 hasConcept C46699223 @default.
- W2005993464 hasConcept C512716672 @default.
- W2005993464 hasConcept C54355233 @default.
- W2005993464 hasConcept C71315377 @default.
- W2005993464 hasConcept C71924100 @default.
- W2005993464 hasConcept C86803240 @default.
- W2005993464 hasConceptScore W2005993464C126322002 @default.
- W2005993464 hasConceptScore W2005993464C143228043 @default.
- W2005993464 hasConceptScore W2005993464C170493617 @default.
- W2005993464 hasConceptScore W2005993464C187785154 @default.
- W2005993464 hasConceptScore W2005993464C191093355 @default.
- W2005993464 hasConceptScore W2005993464C2777886879 @default.
- W2005993464 hasConceptScore W2005993464C2778782382 @default.
- W2005993464 hasConceptScore W2005993464C2778938600 @default.
- W2005993464 hasConceptScore W2005993464C2779234561 @default.
- W2005993464 hasConceptScore W2005993464C2781065240 @default.
- W2005993464 hasConceptScore W2005993464C29456083 @default.
- W2005993464 hasConceptScore W2005993464C46699223 @default.
- W2005993464 hasConceptScore W2005993464C512716672 @default.
- W2005993464 hasConceptScore W2005993464C54355233 @default.
- W2005993464 hasConceptScore W2005993464C71315377 @default.
- W2005993464 hasConceptScore W2005993464C71924100 @default.
- W2005993464 hasConceptScore W2005993464C86803240 @default.
- W2005993464 hasLocation W20059934641 @default.
- W2005993464 hasOpenAccess W2005993464 @default.
- W2005993464 hasPrimaryLocation W20059934641 @default.
- W2005993464 hasRelatedWork W1943881629 @default.
- W2005993464 hasRelatedWork W1979801337 @default.
- W2005993464 hasRelatedWork W2026821716 @default.
- W2005993464 hasRelatedWork W2074723770 @default.
- W2005993464 hasRelatedWork W2133328152 @default.
- W2005993464 hasRelatedWork W2150329447 @default.
- W2005993464 hasRelatedWork W2529704402 @default.
- W2005993464 hasRelatedWork W2942352855 @default.
- W2005993464 hasRelatedWork W4249906845 @default.
- W2005993464 hasRelatedWork W2337586085 @default.
- W2005993464 hasVolume "84" @default.
- W2005993464 isParatext "false" @default.
- W2005993464 isRetracted "false" @default.
- W2005993464 magId "2005993464" @default.
- W2005993464 workType "article" @default.